Monographie - Bevacizumab - Stabilis 4.0

Seneste opdatering :
19/11/2024

anticancer medicin

Bevacizumab

Injektion

Øjendråber

Stabilitet i (vandige) opløsninger

Stabilitet i blandinger

Faktorer der påvirker stabiliteten

Kompatibilitet

Administrationsvej

Bibliografi

pdf

Handelsnavn

Handelsnavn

Handel navne er vejledende og hjælpestoffer sammensætning kan være forskellig afhængigt af landet og laboratorier

Altuzan	Tyrkiet
Alymsis	Frankrig
Avastin	Argentina, Australien, Belgien, Brasilien, Canada, Chile, Colombia, Danmark, Finland, Forenede Arabiske Emirater, Frankrig, Grækenland, Holland, Irland, Island, Italien, Japan, Luxemborg, Malaysia, Marokko, Marokko, Mexico, New Zealand, Norge, Polen, Portugal, Rumænien, Schweiz, Spanien, Storbritanien, Sverige, Tunesien, Tyskland, Ungarn, USA, Venezuela, Østrig
Aybintio	Frankrig
Bevax	Argentina
Zyrabev	Frankrig

Bibliografi

Injektion

Bibliografi : Bevacizumab

	Type	offentliggørelse
2296	Laboratorium	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
2661	Journal	Khalili H, Sharma G, Froome A, Khaw P.T, Brocchini S. Storage stability of bevacizumab in polycarbonate and polypropylene syringes Eye 2015 ; 29, 6: 820-827.
2882	Poster	Morand K, Paul M, Lahlou A, Blanchet B, Astier A. Stabilité de solutions diluées de bévacizumab en fonction de la température. SFPO Congress 2009
3265	Poster	Vieillard V, Cauvin A, Roumi E, Despiau MC, Laurent M, Voytenko S, Astier A, Paul M. Stabilité physico-chimique du bévacizumab à 25 mg/mL conservée à 4°C en seringue polypropylène. SFPO Congress, France 2011
3312	Journal	Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A. Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration. Ann Pharm Fr 2012 ; 70, 3: 139-154.
4467	Laboratorium	Avastin - Summary of Product Characteristics Roche Products Limited 2020
4516	Journal	Seckute J, Castellanos I, Bane S. Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags. GaBI Journal 2020 ; 9, 4:155-162
4525	Journal	Park D, Kim J, Yun J, Park S.J. Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions. Adv Ther 2020 ; 37: 4308–4324.
4714	Poster	Vieillard V, Paul M Etude de stabilité d'un biosimilaire du Bevacizumab dans les flacons et après dilution dans du NaCl 0.9% en poche de polyoléfine. GERPAC Congrès - octobre 2022 2022
4744	Laboratorium	Stability Report of Extended SB8 Opened Vial (400 mg) Stability (personal communication). Samsung laboratory 2023
4745	Journal	Vieillard V, Paul M Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags. Pharmaceutical Technology in Hospital Pharmacy 2023
4756	Journal	Weiser S, Burns C, Zartler E. Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice 2022 ;29, 5: 1032-1043
4798	Journal	Gjølberg T, Lode H, Melo G, Mester S,Probst C, Sivertsen M, Jørstad ø, Andersen J, Moe M. A silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics. Frontiers in Ophthalmology 2022 ;2

Mentions Légales